News
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 until after that year's election, the Wall Street Journal ...
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against Covid-19 until after the election that Trump lost to Biden.
14don MSN
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the nation’s health agencies and closing ...
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating whether or not the ...
Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.
A senior GSK scientist, who formerly worked at rival Pfizer, had told GSK colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election.
March 27 (Reuters) - Federal prosecutors in Manhattan are probing a claim by GSK (GSK.L), opens new tab that Pfizer (PFE.N), opens new tab delayed announcing its COVID shot's success in 2020 until ...
US Prosecutors Probe Tip About Timing of Pfizer's COVID Vaccine, WSJ Reports (Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results